The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3′ untranslated region
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LDLR 3′UTR contains cis-regulating elements that modulate the rate of LDLR mRNA degradation through interaction with trans-regulatory RNA binding proteins.
“Embedded within the LDLR 3′UTR are several cis-regulating elements that modulate the rate of LDLR mRNA degradation through their interaction with trans-regulatory RNA binding proteins8,13.”
From Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA (2018) · cites this paper as [8]
The Results and Discussion show that several cis-acting elements in the LDLR 3′UTR affect mRNA turnover in HepG2 cells. The Discussion describes interactions between AU-rich elements and RNA-binding proteins as a general mechanism, but does not establish that the LDLR elements regulate degradation through such interactions. The indexed passages do not provide section-specific page numbers. (LLM, conf=0.86)
Experimental — accuracy not yet measuredLDLR mRNA contains three adenine-uridine rich elements (AREs) within the 3'UTR.
“LDLR mRNA contains three adenine-uridine rich elements (AREs) within the 3’UTR60,61.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [60]
LDLR gene expression is subject to posttranscriptional regulation at the point of mRNA stability.
“In addition to transcriptional regulation, LDLR gene expression is subject to posttranscriptional regulation at the point of mRNA stability”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [8]
Post-transcriptional regulation of LDLR is mainly achieved through modulation of its mRNA stability.
“The post-transcriptional regulation of LDLR is mainly achieved through modulation of its mRNA stability8–11.”
From Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA (2018) · cites this paper as [8]
The LDLR mRNA 3′ UTR harbors four AU-rich elements (AREs) that are docking sites for cytoplasmic ARE-binding proteins.
“This region harbors four adenylate-uridylate (AU)-rich elements (AREs)”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AU-rich elements: characterization and importance in mRNA degradation
Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
Flagged first, then by citations
Research works printed but not linked: 31
- Goldstein, 1984, Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol, J. Lipid Res., 25, 1450, 10.1016/S0022-2275(20)34418-7 · DOI
- Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311 · DOI · Paper page
- Dietschy, 1970, Regulation of cholesterol metabolism (part 3), N. Engl. J. Med., 282, 1241, 10.1056/NEJM197005282822206 · DOI
- Goldstein, 1977, The low-density lipoprotein pathway and its relation to atherosclerosis, Annu. Rev. Biochem., 46, 897, 10.1146/annurev.bi.46.070177.004341 · DOI · Paper page
- Hobbs, 1990, The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein, Annu. Rev. Genet., 24, 133, 10.1146/annurev.ge.24.120190.001025 · DOI · Paper page
- Bilheimer, 1984, Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia, N. Engl. J. Med., 311, 1658, 10.1056/NEJM198412273112603 · DOI
- Grossman, 1994, Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia, Nature Genet., 6, 335, 10.1038/ng0494-335 · DOI
- Javitt, 1990, HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids, FASEB J., 4, 161, 10.1096/fasebj.4.2.2153592 · DOI
- Knowles, 1980, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science, 209, 497, 10.1126/science.6248960 · DOI
- Kraft, 1992, Regulation of LDL receptor, apoB, and apoE protein and mRNA in HepG2 cells, DNA Cell Biol., 11, 291, 10.1089/dna.1992.11.291 · DOI
- Tam, 1991, Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels, J. Biol. Chem., 266, 16764, 10.1016/S0021-9258(18)55366-7 · DOI
- Illingworth, 1984, Regulation of low-density lipoprotein receptors in the human hepatoma cell line HepG2, Exp. Cell Res., 155, 518, 10.1016/0014-4827(84)90211-8 · DOI
- Kamps, 1992, Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line HepG2 by β-migrating very-low-density-lipoprotein and non-lipoprotein cholesterol, Eur. J. Biochem., 206, 973, 10.1111/j.1432-1033.1992.tb17008.x · DOI
- Auwerx, 1989, Involvement of second messengers in regulation of the low-density lipoprotein receptor gene, Mol. Cell. Biol., 9, 2298
- Auwerx, 1989, Regulation of the low density lipoprotein receptor and hydroxymethylglutaryl coenzyme A reductase genes by protein kinase C and a putative negative regulatory protein, Proc. Natl. Acad. Sci. USA, 86, 1133, 10.1073/pnas.86.4.1133 · DOI
- Kamps, 1993, Regulation of low-density-lipoprotein receptors in the human hepatoma cell line HepG2, Eur. J. Biochem., 213, 989, 10.1111/j.1432-1033.1993.tb17845.x · DOI
- Iyengar, 1996, Gating by cyclic AMP: expanded role for an old signalling pathway, Science, 271, 461, 10.1126/science.271.5248.461 · DOI
- Clapham, 1995, Calcium signalling, Cell, 80, 259, 10.1016/0092-8674(95)90408-5 · DOI
- Haller, 1994, Role of protein kinase C in intracellular signalling, Ann. NY Acad. Sci., 733, 313, 10.1111/j.1749-6632.1994.tb17281.x · DOI
- Wilson, 1997, Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models, J. Lipid Res., 38, 437, 10.1016/S0022-2275(20)37252-7 · DOI · Paper page
- Wilson, 1995, An episomal expression vector system for monitoring sequence-specific effects on mRNA stability in human cell lines, Plasmid, 33, 198, 10.1006/plas.1995.1021 · DOI
- Feinberg, 1984, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem., 137, 266, 10.1016/0003-2697(84)90381-6 · DOI
- Zambetti, 1990, Differential association of membrane-bound and non-membrane bound polysomes with the cytoskeleton, Exp. Cell Res., 191, 246, 10.1016/0014-4827(90)90011-X · DOI
- Zubiaga, 1995, The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation, Mol. Cell. Biol., 15, 2219, 10.1128/MCB.15.4.2219 · DOI
- Ross, 1995, mRNA stability in mammalian cells, Microbiol. Rev., 59, 423, 10.1128/mr.59.3.423-450.1995 · DOI · Paper page
- DeMaria, 1996, AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation, J. Biol. Chem., 271, 12179, 10.1074/jbc.271.21.12179 · DOI
- Chen, 1994, Defining a novel ribonucleotide reductase R1 mRNA cis-element that binds to a unique cytoplasmic trans-acting protein, Nucleic Acids Res., 22, 4796, 10.1093/nar/22.22.4796 · DOI
- Amara, 1996, Defining a novel cis-element in the 3′-untranslated region of mammalian ribonucleotide reductase component R2 mRNA. cis–trans-interactions and message stability, J. Biol. Chem., 271, 20126, 10.1074/jbc.271.33.20126 · DOI
- Chen, 1993, Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis–trans interaction at the 3′ untranslated region, EMBO J., 12, 3977, 10.1002/j.1460-2075.1993.tb06075.x · DOI
- Ross, 1997, Characterization of a β-actin mRNA zipcode-binding protein, Mol. Cell. Biol., 17, 2158, 10.1128/MCB.17.4.2158 · DOI
- Hesketh, 1996, Sorting of messenger RNAs in the cytoplasm: mRNA localization and the cytoskeleton, Exp. Cell Res., 225, 219, 10.1006/excr.1996.0172 · DOI
Cited by
Sorted by citations
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
Bjune, K., Wierød, L., & Naderi, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-34237-6 · Cited by 36
Singh, A. B., Kan, C. F. K., Shende, V., Dong, B., & Liu, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m049429 · Cited by 35
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., de Aguiar Vallim, T. Q., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 33
Singh, A. B., Li, H., Kan, C. F. K., Dong, B., Nicolls, M. R., & Liu, J. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301131 · Cited by 32
The low-density lipoprotein receptor: Emerging post-transcriptional regulatory mechanisms
Ndoj, K., Meurs, A., Papaioannou, D., Bjune, K., & Zelcer, N. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119082 · Cited by 17
Metadata
- Authors
- Wilson, G. M., Vasa, M. Z., & Deeley, R. G.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1998-05
- Volume
- 39
- Issue
- 5
- Pages
- 1025-1032
- ISSN
- 0022-2275
- Cited by
- 54
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review